[{"Assets_0_Q1_USD":519031000.0,"CommonStockSharesOutstanding_0_Q1_shares":36611000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-29297000.0,"NetIncomeLoss_1_Q1_USD":-32228000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":36366000.0,"StockholdersEquity_0_Q1_USD":487053000.0,"EarningsPerShareBasic_1_Q1_USD":-0.89,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]